Catalyst Wire Dossier Catalyst Wire Dossier

Licarbazepine

licarbazepine · Novartis
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Licarbazepine, covering 2007-06-22 to 2017-03-28. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder [Phase 3]

See pricing